Skip to main content

olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide

NDC 72162-1514 · Bryant Ranch Prepack

Generic nameolmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE
Strength5; 12.5; 20 mg/1; mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

72162-1514-3 — 30 TABLET, FILM COATED in 1 BOTTLE (72162-1514-3)

72162-1514-9 — 90 TABLET, FILM COATED in 1 BOTTLE (72162-1514-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71610-888 — Amlodipine Besylate, 71610-928 — Amlodipine Besylate, 71610-938 — Amlodipine Besylate, 71610-956 — Amlodipine Besylate, 71610-978 — AMLODIPINE BESYLATE, 71610-985 — AMLODIPINE BESYLATE, 71610-988 — Amlodipine Besylate, 72162-1035 — Irbesartan and Hydrochlorothiazide, 72162-1084 — Triamterene and Hydrochlorothiazide, 72162-1357 — Hydrochlorothiazide, 72162-1515 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 72162-1516 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 72162-1528 — Hydrochlorothiazide, 72162-1625 — Spironolactone and Hydrochlorothiazide, 72162-1700 — losartan potassium and hydrochlorothiazide, 72162-1701 — losartan potassium and hydrochlorothiazide, 72162-2090 — Amlodipine and Atorvastatin, 72162-2091 — Amlodipine and Atorvastatin, 72162-2092 — Amlodipine and Atorvastatin, 72162-2093 — Amlodipine and Atorvastatin, +1450 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels